DA Davidson Cuts USANA Health Sciences (NYSE:USNA) Price Target to $38.00

USANA Health Sciences (NYSE:USNA) had its price objective decreased by DA Davidson from $46.00 to $38.00 in a research note issued to investors on Thursday, Benzinga reports. DA Davidson currently has a neutral rating on the stock. DA Davidson also issued estimates for USANA Health Sciences’ Q3 2024 earnings at $0.46 EPS.

Separately, StockNews.com lowered shares of USANA Health Sciences from a strong-buy rating to a buy rating in a research report on Wednesday, July 24th.

USANA Health Sciences Stock Up 1.9 %

USANA Health Sciences stock opened at $42.62 on Thursday. The company has a market capitalization of $811.91 million, a PE ratio of 13.28, a PEG ratio of 1.43 and a beta of 0.90. USANA Health Sciences has a 12-month low of $40.51 and a 12-month high of $68.00. The firm’s fifty day moving average is $46.01 and its 200 day moving average is $46.92.

USANA Health Sciences (NYSE:USNA) last posted its quarterly earnings results on Tuesday, July 23rd. The company reported $0.54 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.65 by ($0.11). USANA Health Sciences had a net margin of 6.29% and a return on equity of 11.13%. The business had revenue of $212.87 million during the quarter, compared to analyst estimates of $218.64 million. During the same period in the previous year, the business posted $0.89 EPS. Sell-side analysts expect that USANA Health Sciences will post 2.5 EPS for the current fiscal year.

Insider Buying and Selling

In other news, CFO G Doug Iiekking sold 5,198 shares of the stock in a transaction dated Tuesday, May 7th. The stock was sold at an average price of $44.76, for a total transaction of $232,662.48. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. In other news, insider Daniel A. Macuga sold 3,791 shares of the stock in a transaction dated Thursday, May 2nd. The shares were sold at an average price of $47.14, for a total transaction of $178,707.74. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO G Doug Iiekking sold 5,198 shares of the business’s stock in a transaction that occurred on Tuesday, May 7th. The shares were sold at an average price of $44.76, for a total value of $232,662.48. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 31,591 shares of company stock worth $1,458,098. Corporate insiders own 0.33% of the company’s stock.

Institutional Trading of USANA Health Sciences

A number of hedge funds have recently modified their holdings of USNA. CWM LLC grew its stake in shares of USANA Health Sciences by 21.8% in the 1st quarter. CWM LLC now owns 1,543 shares of the company’s stock worth $75,000 after buying an additional 276 shares during the last quarter. New York State Common Retirement Fund boosted its stake in USANA Health Sciences by 1.2% in the 4th quarter. New York State Common Retirement Fund now owns 24,500 shares of the company’s stock worth $1,313,000 after purchasing an additional 279 shares in the last quarter. Price T Rowe Associates Inc. MD grew its position in USANA Health Sciences by 9.2% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 5,849 shares of the company’s stock valued at $284,000 after purchasing an additional 494 shares during the last quarter. Strs Ohio increased its stake in USANA Health Sciences by 9.2% during the 4th quarter. Strs Ohio now owns 11,900 shares of the company’s stock valued at $637,000 after purchasing an additional 1,000 shares in the last quarter. Finally, Quest Partners LLC purchased a new position in USANA Health Sciences in the fourth quarter worth about $66,000. Institutional investors own 54.25% of the company’s stock.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.